Risk of AML and Potential Use of Bone Marrow Transplant in Patients with MF

Srdan Verstovsek, MD, PhD, discusses the risk of transformation to acute myeloid leukemia (AML) and the potential use of bone marrow transplant in patients with MF.

Related Videos
John Allan, MD, an expert on chronic lymphocytic leukemia